The market potential for Her-Vaxx in China (due to very high gastric cancer rates) is another addition to IMU's attractiveness.
China is becoming the worlds leading economy in at least scale so having a profound cancer therapy there can only increase the value case of IMU.
Valuing IMU is becoming very difficult though, there are so many variables that all I can think to do is put my stock to one side and let science and our fantastic management do their thing.
DYOR.
Ann: Imugene HER-Vaxx Immunotherapy Patent Allowed in China, page-15
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |